L-Ofloxacin
Febrile Neutropenia
Minsk Scientific-Practical Center for Surgery, Transplantation and HematologySmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 53/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Febrile Neutropenia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Conjugated Pneumococcal Vaccine Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology | Phase 4 | BB |
Rhgm-Csf Jiangsu HengRui Medicine Co., Ltd. | Phase 3 | BB |
Pegylated Rhg-Csf Jiangsu HengRui Medicine Co., Ltd. | Phase 3 | BB |
PEGFILGRASTIM Asan Medical Center | Phase 3 | BB |
Docetaxel Jiangsu HengRui Medicine Co., Ltd. | Phase 3 | BB |
View all 16 →
Same molecule, other indications
L-Ofloxacin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →